Nurse Practitioner, Adult Health · New York, NY
NPI
1861054587
Since 2019
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
379 E 10th St Apt 2a
New York, NY, 10009
Phone (212) 203-6336
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.4M
1,306 prescriptions
Company payments, 2025
$164
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany Tomberlin prescribed most often to Medicare patients was Abiraterone Acetate, with 335 prescriptions and refills. In total Tiffany Tomberlin wrote 1,306 Medicare prescriptions that cost $3.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Abiraterone Acetate Generic | 335 | 360 | 51 | $757K |
| Prednisone Generic | 288 | 330 | 65 | $991 |
| Orgovyx Relugolix | 233 | 243 | 37 | $627K |
| Xtandi Enzalutamide | 61 | 61 | 15 | $610K |
| Nubeqa Darolutamide | 59 | 59 | 11 | $750K |
| Tamsulosin Hcl Generic | 43 | 77 | 12 | $531 |
| Dexamethasone Generic | 40 | 46 | Under 11 | $243 |
| Ondansetron Hcl Generic | 25 | 25 | 12 | $129 |
| Bicalutamide Generic | 22 | 44 | Under 11 | $627 |
| Zytiga Abiraterone Acetate | 21 | 21 | Under 11 | $161K |
| Eliquis Apixaban | 17 | 23 | Under 11 | $13K |
| Lynparza Olaparib | 17 | 17 | Under 11 | $255K |
| Gabapentin Generic | 17 | 26 | Under 11 | $66.99 |
| Oxycodone Hcl Generic | 12 | 12 | Under 11 | $154 |
| Klor-Con M20 Potassium Chloride | 12 | 18 | Under 11 | $74.09 |
Brand drugs: 438 claims; generic drugs: 868 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany Tomberlin $164 ($164 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Scientific Affairs, LLC with $129.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.